WGS GeneDx Holdings Corp.

8-K Current Report

Filed: March 2, 2026

Health Care

Services-Health Services

GeneDx Holdings Corp. (WGS) 8-K current report filed with SEC EDGAR on March 2, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 1.01: Entry into a Material Definitive Agreement

AI Filing Analysis
8-K

Item 1.01 · Entry into a Material Definitive Agreement

• Filing signed March 2, 2026 by CEO Katherine Stueland, confirming a new Loan Agreement (Term Loan) is material enough to trigger 8-K disclosure
• Term Loan proceeds use is referenced but specific amount, rate, and maturity not disclosed in this section — key terms likely in full exhibit

+1 more insights

Other GeneDx Holdings Corp. 8-K Filings

8-K Feb 23, 2026

Get deeper insights on GeneDx Holdings Corp.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.